|Articles|July 1, 2001
- Applied Clinical Trials-07-01-2001
Affairs of State
As FDA monitors more international clinical trials, new policies aim to address differences in national approaches to such issues as placebos and protocols.
Advertisement
Articles in this issue
about 25 years ago
Letters to the Editorabout 25 years ago
Conference Reportsabout 25 years ago
Pen-Based Computingabout 25 years ago
Some Do--Some Watch Over Those Who Doabout 25 years ago
Communication Skills for Monitors—A Vital Training Opportunityabout 25 years ago
ACT 101 Human Safety in Clinical ResearchAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Reaffirms GCP Standards Amid Growing Concerns Over Foreign Clinical Trial Data
2
Beyond Patient Centricity: What Rare Disease Research Gets Right
3
Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services Division in $45 Million Deal
4
ACT Brief: Human Readiness as Operational Foundation, Early Phase Capacity Consolidation, and AI-Driven Patient Matching Scale
5